[go: up one dir, main page]

EE9900092A - PTX-tundlikud G-valgud, nende valmistamine ja kasutamine - Google Patents

PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Info

Publication number
EE9900092A
EE9900092A EEP199900092A EE9900092A EE9900092A EE 9900092 A EE9900092 A EE 9900092A EE P199900092 A EEP199900092 A EE P199900092A EE 9900092 A EE9900092 A EE 9900092A EE 9900092 A EE9900092 A EE 9900092A
Authority
EE
Estonia
Prior art keywords
ptx
proteins
sensitive
preparation
Prior art date
Application number
EEP199900092A
Other languages
English (en)
Inventor
Siffert Winfried
Original Assignee
Siffert Winfried
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siffert Winfried filed Critical Siffert Winfried
Publication of EE9900092A publication Critical patent/EE9900092A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722G-proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
EEP199900092A 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine EE9900092A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
EE9900092A true EE9900092A (et) 1999-10-15

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900092A EE9900092A (et) 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Country Status (22)

Country Link
US (1) US6251853B1 (et)
EP (1) EP0931145A1 (et)
JP (1) JP2001501811A (et)
KR (1) KR20000036058A (et)
CN (1) CN1230222A (et)
AU (1) AU4619297A (et)
BG (1) BG103238A (et)
BR (1) BR9711475A (et)
CA (1) CA2265467A1 (et)
CZ (1) CZ73499A3 (et)
DE (1) DE19637518A1 (et)
EA (1) EA199900253A1 (et)
EE (1) EE9900092A (et)
HU (1) HUP9904110A3 (et)
IL (1) IL128746A0 (et)
IS (1) IS4987A (et)
NO (1) NO991227L (et)
PL (1) PL332417A1 (et)
SK (1) SK34099A3 (et)
TR (1) TR199900500T2 (et)
WO (1) WO1998011212A1 (et)
ZA (1) ZA978220B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
AU3975799A (en) * 1998-05-11 1999-11-29 Axys Pharmaceuticals, Inc. (rhoh) genes and their uses
DE59913114D1 (de) * 1998-09-10 2006-04-20 Eurofins Medigenomix Gmbh GENVERÄNDERUNG IM GEN FÜR DIE G DOLLAR g(b)3-UNTEREINHEIT DES HUMANEN G-PROTEINS
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
WO2001057246A1 (de) * 2000-02-03 2001-08-09 Winfried Siffert VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE β3-UNTEREINHEIT DES HUMANEN G-PROTEINS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
BR9711475A (pt) 1999-08-24
JP2001501811A (ja) 2001-02-13
BG103238A (bg) 2000-06-30
CZ73499A3 (cs) 1999-07-14
CN1230222A (zh) 1999-09-29
ZA978220B (en) 1999-03-12
CA2265467A1 (en) 1998-03-19
HUP9904110A3 (en) 2001-09-28
DE19637518A1 (de) 1998-04-09
EP0931145A1 (de) 1999-07-28
AU4619297A (en) 1998-04-02
TR199900500T2 (xx) 1999-06-21
SK34099A3 (en) 2000-05-16
EA199900253A1 (ru) 1999-10-28
KR20000036058A (ko) 2000-06-26
PL332417A1 (en) 1999-09-13
WO1998011212A1 (de) 1998-03-19
IS4987A (is) 1999-02-26
HUP9904110A2 (en) 2000-07-28
IL128746A0 (en) 2000-01-31
US6251853B1 (en) 2001-06-26
NO991227D0 (no) 1999-03-12
NO991227L (no) 1999-03-12

Similar Documents

Publication Publication Date Title
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
BR9708400A (pt) Composição sua preparação e uso
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
ID16224A (id) Bikunin manusia
DE69727572D1 (de) Wässrige peptidzubereitung
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
NO985464D0 (no) Konsentrert antistoffpreparat
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI990134L (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
DE59707298D1 (de) Desodorierende zubereitungen
FI970997L (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI963334L (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
FI951726A7 (fi) Boronihappopeptidijohdannaisia, niiden valmistus ja käyttö synteesivälituotteina
EE9800451A (et) Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
TR199701666A3 (tr) Sismanliga karsi proteinler
FI972965A7 (fi) Uusia peptidejä, niiden valmistus ja käyttö
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI950516L (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
FI971317A7 (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
FI971872A0 (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
FI964446L (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö
FI965172A7 (fi) Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö